In order to overcome those drawbacks, recent research has been focusing on molecularly targeted MRI probes, in particular those conjugated to biomolecules—including carbohydrates—to improve selective uptake into cancer cells via GLUT-mediated pathways (Figure 16). This evidence concerns the gene SLC2A1 and cancer.